We came across a bullish thesis on Avid Bioservices, Inc. (CDMO) on Twitter by northeasternsvf. In this article, we will ...

【欧盟将于12月6日前对诺和诺德收购Catalent作出裁决】根据欧盟委员会网站周一发布的文件，欧盟反垄断监管机构将在12月6日之前决定是否批准诺和诺德(NVO.US)收购美国合同制药商Catalent。文件显示，诺和诺德控股股东于10月31日向欧盟提交了批准该交易的请求。欧盟反垄断监管机构可以在有或没有补救措施的情况下批准这笔交易，也可以在有严重担忧的情况下展开为期4个月的全面调查。

OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced its roster of keynote and guest speakers for OpenText World 2024, the leading information management conference, set to take place in-person and ...

Read the Market Summary Here @- Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Vietnam Prefilled Syringes Market size at USD 58.41 million in ...

根据最近的SEC文件显示，Catalent, Inc. (NYSE:CTLT)的董事Ryan Michelle R近期出售了2,800股公司普通股。每股售价为59.70美元，总交易价值为167,160美元。此次出售后，Ryan Michelle R现持有10,835股，包括限制性股票单位。这些股票的出售是为了支付之前根据Catalent非雇员董事薪酬计划授予的限制性股票单位相关的税款。

The European Commission is seeking feedback from industry players about Novo Holdings' $16.5 billion proposed acquisition of ...

A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...